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Abstract
The work presented here was performed in conjunction with an experimental group in order to
prove the concept that an alternating magnetic field (AMF) could be used to induce an
intramolecular cyclization to effect payload release. The system studied here consisted of a
fluorophore tethered to gold-coated iron oxide nanoparticles (Fe3O4 NPs) via an organic linker
consisting of 2 key elements: a carbonate (electrophile) and an amine (nucleophile). Connected
to the carbonate was the fluorophore, anthracene, which was attached to the organic linker
system by means of an oxime ether linkage. This thesis work served as the control group for the
study by examining the absence of the amine. The control linker system was synthesized over 5
steps with a 53% overall yield. The amine-deficient control system, containing a thiol and
carbonate group, was then covalently bound to gold-coated Fe3O4 NPs. The system was then
subjected to an alternating magnetic field to promote local hyperthermia which would drive
payload release for the experimental group but not for the control group due to the lack of a
nucleophilic element. The control system was subjected to the AMF and analytical methods
were performed on the supernatant of the solution by matrix-assisted laser
desorption/ionization time of flight (MALDI-TOF). Results concluded that the control system
withstood AMF exposure and retained its payload. Further studies were performed using
lithium aluminum hydride (LAH) and dithiothreitol (DTT) on the control system in order to
prove that the payload was indeed present on the system. Comparing the results obtained on
the control system with that of the experimental system, intramolecular cyclization is proven to
be the preferred mechanism of payload release.
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Lay Summary
In this work, the control group of a gold nanoparticle-bound molecular delivery system was
designed and tested. The purpose of this work was to prove that a payload is released by a
specific mechanism. The control system was designed by removing one vital atom responsible
for an important role in the mechanism. With this one atom missing, the payload would be
unable to release, thus proving that release likely occurs by this proposed cyclization
mechanism. After testing the control system, it was discovered that no payload had released,
thus supporting the proposed mechanism. Additional testing was performed in order to prove
that the payload was indeed attached to the control system. With this evidence in hand, we
conclude that the molecular release system occurs by the cyclization mechanism that was
hypothesized.
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Chapter 1
Part A: Introduction
The utilization of natural compounds for the treatment of diseases dates back
thousands of years. One of the oldest known medical texts, the Ebers Medical Papyrus from
ancient Egypt, suggests using honey (Figure 1) to treat infections and a mixture of berries from
the castor oil tree, Gengent beans, and Male Palm to cure constipation.1

Figure 1. Egyptian relief depicting the process of collecting honey as a “beekeeper.” Honey was
a large part of Egyptian culture used in many parts of daily life, such as cooking and medicinal
practices.

1

Without knowledge of the chemical or molecular identities of the active ingredients, the
Egyptians used dozens of plants for medicinal actions, building a foundation for what would
become the beginning of pharmacology. Later in history, as scientists theorized that medicinal
outcomes were the result of molecular interactions at the cellular level, a more modern form of
pharmacology flourished. Instead of investigating crude extracts, an emphasis was placed on
the effects of pure compounds at both the cellular and organ system level, giving rise to drugs
such as morphine. Coupled with the field of organic chemistry, many natural products from
biological sources have been successfully synthesized and incorporated into modern medicine.
However, while these medicines can be beneficial, they can also have devastating effects at
high concentrations in the body. Often the danger is related to a compound’s effect on a
specific organ, such as with cardiotoxicity, for example. While a drug may aid one system, it can
be detrimental to others. These dangers are what have encouraged the development of
methods for drug delivery, which generally utilize a controlled-release mechanism to ensure
drug release at a target site. Delivery systems allow administration of compounds with the
options of selecting how much, where, and even when a drug will become active, thus reducing
the harm associated with a systemically circulating drug.

2

Part B: Background
Stimuli-Responsive Linkers. Mimicking the function of transport proteins to aid in trafficking
hormones so as to mitigate their premature metabolism, the covalent attachment of a
molecular payload, such as a drug, to nanoparticles can similarly resolve the problem of
premature release (i.e., leeching). Covalent attachment can also render the payload
pharmaceutically inactive until release occurs. A stimulus, ideally one that can be triggered,
generally is required to cleave the covalent linkage for payload release to occur. Such a stimulus
can be external to the targeted treatment site to afford both spatial and temporal control over
release – this is highly desired. Most common, however, is use of an internal stimulus, such as a
change in pH. With the slightly acidic exterior environment of a cancerous cell (pH 5.0)
compared to the physiological environment of healthy cells (pH 7.4), a decrease in pH is just
one avenue by which a change in the chemical environment can be used as a release stimulus.
For example, Aryal et al.2 demonstrated that an acidic environment promoted the cleavage
(i.e., hydrolysis) of a hydrazone linkage formed by reaction of a hydrazine-functionalized linker
motif with the C(13) ketone moiety in doxorubicin (Dox) (Figure 2). The authors also noted,
however, that the drug Dox was slowly released even without an acid environment, at
physiological pH (i.e., leeching occurred). These findings illustrate the unpredictability of a
dynamic chemical environment and the challenges associated with designing a release trigger.

3

Figure 2. Dox derivatization by hydrazine reagent to afford a Dox-hydrazone

Payload Release Caused by Thermally-Induced Cyclization. Knipp et al.3 explored development
of a substrate release mechanism that relies on a thermally-induced intramolecular cyclization
as the trigger for payload release. The system was designed for use within a
poly(dimethylsiloxane) microchannel. Several substrates that differed in linker length and
functionality were tested for heat-induced intramolecular cyclization (Figure 3). The studies
revealed that ester and carbonate moieties cyclized much more efficiently with mild heating
(Figure 3). Upon testing for the optimal ring size for cyclization, Knipp et al. determined that the
5- and 6- member rings released a greater proportion of payload when heated at 55 ⁰C as
compared to the 7-member ring system. The carbonate moiety (Figure 3, structure 2) that
formed a 5-member ring upon cyclization was chosen for microchannel demonstrations.
4

Figure 3. Cyclization substrates examined by Knipp et al.3

Figure 4. Intramolecular Cyclization upon heating.

Thermally Reactive Linker for Fe3O4-Silica Core-Shell NPs. Knipp et al. applied the
thermoresponsive linker concept to nanoparticles (NPs) using an Fe3O4-silica core-shell system.3
A fluorophore was used as the payload for this experiment. As desired, the fluorophore was
5

released as a result of an intramolecular cyclization of the linker upon exposure to an
alternating magnetic field (AMF). As a result of the AMF, the magnetic moments of the NPs
rapidly change, resulting in a phenomenon called Neel relaxation. Additionally, under the
influence of the AMF, the NPs create friction with the medium as they physically rotate in
conjunction with the rapidly changing magnetic field, a phenomenon known as Brownian
relaxation. 4 The combination of these two phenomena creates the local hyperthermia which
distributes into the medium so as to heat the bulk solution. In this experiment, the AMF induces
heating of the magnetic core of the nanoparticle system, which in turn powers re-cyclization by
providing the necessary energy required to overcome the activation energy associated with the
intramolecular attack.
In order to prove the veracity of the cyclization mechanism of release, a similar
experiment was conducted implementing a Boc-protected amine, which prevents
intramolecular cyclization of the amine. However, even with the Boc-protecting group, the
fluorophore was still released, albeit at a slower rate than with the free amine. The authors
attributed this leeching to the Lewis acidity of the silica shell functioning to catalyze carbamate
hydrolysis on heating. The authors then sought to exploit this observation by designing a
carbamate-based linker devoid of the amine (Figure 5).

6

Figure 5. Linker-NP heating via AMF for payload release, Ar = anthracene
To allow for a simpler conjugation of the fluorophore to the linker, oxime ether formation
between a linker-bound aminooxy moiety and an aldehyde moiety on the fluorophore was
explored. This adjustment appeared to resolve the premature release of the fluorophore.
However, at 37 ⁰C a trace amount of payload release did occur without AMF exposure. Given
that gold is appreciably well tolerated by the body, and that gold is more inert than a silica
coating as well as more readily functionalized, the present thesis work seeks to explore the use
of gold-coated iron oxide NPs as the core of a triggerable delivery system.
Fe3O4-Gold Core Shell Nanoparticles. Gold NP systems have been utilized as drug delivery
systems, as well as in delivery applications involving AMF exposure, due largely to their
biocompatible properties.5 Unlike iron oxide particles, gold is not superparamagnetic; however,
it can absorb6 and scatter7 laser radiation in the near-IR region as a result of surface plasmon
resonance (SPR). Guo et al. synthesized Fe3O4-Au core-shell NPs for photothermal ablation of
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pancreatic cells using laser irradiation, 8 and Mohammad et al. synthesized Fe3O4-Au core-shell
NPs with a cysteine coating to deliver Dox to breast cancer cells in vitro.9

Figure 6. PANC-1 cells exposed to 0, 25, and 50 μg/mL dose of nanoparticles, respectively,
without laser irradiation (A–C) and with laser irradiation at 7.9 W/cm2 power density (D–F).8

Figure 6 above shows the results of Guo et al.’s experiment which used laser irradiation
and Fe3O4-Au core-shell NPs to destroy PANC-1 cancer cells. Row A-C received Fe3O4-Au coreshell NPs in concentrations of 0, 25, and 50 μg/mL respectively without laser irradiation. Row DF received Fe3O4-Au core-shell NPs in the same respective concentrations with a laser
irradiation treatment that lasted 5 minutes. The treatment group of cells that received laser
irradiation showed significantly decreased cell proliferation. This experiment demonstrated the
efficacy of utilizing Fe3O4-Au core-shell NPs. 8

8

As a means to overcome the challenge of non-triggered payload release, we will
covalently attach the payload to a linker system that in turn is bound to a NP. The linker will
cyclize to release the payload on exposure (external) to an AMF.

Figure 7. Summary of nucleophilic linker system.

Using Figure 7 above as a visual summary, the complete idea of the experiment can be
understood. Step 1 involves coating Fe3O4 NPs with gold acetate, generating gold-coated Fe3O4
NPs. In Step 2, the gold-coated Fe3O4 NPs will be coated with an amine-based linker system
using well-established thiol-gold monolayer formation.10 The amine-based linker system is
comprised of three important parts: 1.) the nucleophilic element, the amine; 2.) a carbonate,
which provides carbonyl functionality; and 3.) a payload, initially a fluorophore, ultimately a
pharmaceutical such as Doxorubicin. For Step 3, the entire system will be subjected to an AMF

9

to ultimately promote release of the payload by an intramolecular cyclization mechanism.
Analytical processes will then be performed on the supernatant to confirm release of the
payload. 11

Figure 8: Overview of the experiment clarifying my project as the control group.
Figure 8 above is a visual representation of the experiment. As in any scientific research, both
an experimental group and a control group must be designed and tested in order to validate a
hypothesis. For this specific experiment, the experimental group will consist of Sara Biladeau’s
work with her amine-based linker system. This linker system contains the appropriate pieces
necessary for payload release due to intramolecular cyclization. Furthermore, the control group
consists of my work with the amine-deficient linker system. I designed my linker system to be
almost identical to the amine-based linker system in all areas except one—the nucleophilic
amine. By removing the nucleophilic amine portion from the linker system, my linker system
would lack the ability to undergo an intramolecular cyclization and result in payload retention,
10

supporting my hypothesis that the mechanism of payload release is by means of an
intramolecular cyclization mechanism.

11

Part C: Hypothesis and Experimental Aims

I.

Key Objective
To confirm that the 2⁰-amine component of the linker system is essential for AMFtriggered release of the payload. The amine is believed to react with the proximal
carbonate group given sufficient heat generated on AMF exposure, resulting in
payload release. Its absence would obviate payload release via cyclization, the key
mechanistic trigger believed necessary for payload release.

II.

Hypothesis
Removal of the amine from the linker system will result in retention of the payload,
even on exposure to AMF. Without the ability to cyclize, the carbonate group will
not react to release the payload.

III.

Experimental Aims
A. Synthesize a control linker system devoid of amine functionality and containing a
fluorophore (anthracene) to evaluate payload release.
B. Load the linker system onto Fe3O4-gold core-shell nanoparticles.
C. After subjecting the nanoparticle-bound linker system to an alternating magnetic
field as a means of analysis, evaluate payload release using MALDI-TOF.

12

Figure 9. Summary of nucleophilic linker system.

Figure 10. PRESENT THESIS WORK: Summary of control, amine-deficient linker system.
13

Chapter 2
Materials and Methods
The following procedures included below were used to synthesize the amine-deficient linker
system. As a means of characterization of each step, the following spectroscopic techniques
were utilized: Infrared spectroscopy (IR), proton nuclear magnetic resonance spectroscopy ( 1H
NMR), carbon-13 nuclear magnetic resonance spectroscopy (13C NMR), and high-resolution
mass spectrometry (HRMS). For IR, significant peaks representing functional groups present on
the molecule were recorded in cm-1. For 1H and 13C NMR, important peaks were recorded in
parts per million (ppm). For HRMS, findings were recorded as a unit of mass per charge (m/z).
The appropriate spectrum representing the specific spectroscopic method for each molecule
can be found in Chapter 4 matched with its corresponding figure number.
I.

Synthesis of an Amine-free Linker System

6-(Tritylthio)hexan-1-ol (2). 6-bromohexanol (0.526 g, 2.90 mmol) and triphenylmethanethiol
(0.802 g, 2.90 mmol) were added to a solution of K2CO3 (0.802 g, 5.80 mmol) in a 1:1 mixture of
ethanol:water (15.0 mL) at 90 ⁰C. The mixture was stirred for 18 hours. On cooling, the reaction
was quenched by addition of 1M HCl and extracted with dichloromethane (25 mL x 3). The
combined organic layer was washed with water (25 mL) and brine (25 mL), dried over
anhydrous sodium sulfate, filtered, and concentrated by rotary evaporation to give 2 as a
14

yellow oil (0.88 g, 82% yield) which was used in the next step without further purification.
-1

Figure 15. IR ν (cm ) 3341, 1488, 1442; Figure 20. 1H NMR (500 MHz, CDCl3): δ 1.24 (quint, J =
8.5 Hz, 5H), 1.39 (pent, J = 7.0 Hz, 2H), 1.48 (pent, J = 6.5 Hz, 2H), 2.14 (t, J = 7.5 Hz, 2H), 3.58 (t,
J = 6.5 Hz, 2H), 7.19 (t, J = 7.5 Hz, 3H), 7.27 (t, J = 7.5 Hz, 6H), 7.41 (d, J = 8.5 Hz, 6H); Figure 25.
13C

NMR (400 MHz, CDCl3): δ 25.5, 28.7, 28.9, 32.1, 32.7, 63.1, 66.6, 126.7, 128.1, 129.8, 145.4.

6-(Tritylthio)hexyl 1H-imidazole-1-carboxylate (3). 1,1’-carbonyldiimidazole (1.27 g, 7.86
mmol) was added to a solution of N,N-diisopropylethylamine (1.02 g, 7.86 mmol) and 6(tritylthio)hexan-1-ol (1.97 g, 5.24 mmol) in dichloromethane (25 mL) at 0 ⁰C. The reaction was
stirred at room temperature overnight. The reaction mixture then was washed with water (25
mL x2) and extracted with dichloromethane (25 mL). The organic layer was washed with
saturated ammonium chloride (25 mL) and brine (25 mL), dried over anhydrous sodium sulfate,
and concentrated by rotary evaporation to give 3 as a yellow oil which was used without
-1

further purification. Figure 16. IR ν (cm ) 1761, 1486, 1441, 1237; Figure 21. 1H NMR (500 MHz,
CDCl3): δ 1.30 (m, J = 3Hz, 4H), 1.40 (pent, J = 7Hz, 2H), 1.70 (pent, J = 7 Hz, 2H), 2.16 (t, J = 7 Hz,
2H), 4.35 (t, J = 6.5 Hz, 2H), 7.11 (s, 1H), 7.20 (t, J = 7.5Hz, 3H), 7.27 (t, J = 7 Hz, 6H), 7.41 (d, J =
7.5 Hz, 6H), 8.11 (s, 1H), 7.68 (s, 1H); Figure 26. 13C NMR (400 MHz, CDCl3): δ 25.4, 28.4, 28.6,
31.7, 31.9, 66.6, 68.4, 117.2, 126.7, 128.1, 129.7, 130.8, 137.2, 145.1, 148.9; HRMS m/z cald
[C29H32N2O2S]+ 471.2101, observed 471.2096.
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2-((6-(Tritylthio)hexyl)oxy)isoindoline-1,3-dione (4). N-(2-Hydroxyethyl)phthalimide (2.29 g,
11.1 mmol) was added to a solution of 6-(tritylthio)hexyl 1H-imidazole-1-carboxylate (5.21 g,
11.1 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (1.65 mL, 11.1 mmol) in acetonitrile (50 mL)
at room temperature. The reaction was stirred overnight. The reaction was diluted with ethyl
acetate and washed with saturated ammonium chloride (25 mL x 2).The layers were separated
and the aqueous layer was extracted with ethyl acetate (25 mL x 3). The combined organic layer
was washed with brine (25 mL), dried over anhydrous sodium sulfate, filtered, and
concentrated by rotary evaporation to give a residue that was purified by column
chromatography (hexane/ethyl acetate, 7:3) to afford a clear oil (4.48 g, 66% yield over 2
-1

steps). Figure 17. IR ν (cm ) 1790, 1731, 1253; Figure 22. 1H NMR (500 MHz, CDCl3): δ 1.25
(quint, J = 6.5 Hz, 4H), 1.38 (pent, J = 7.0 Hz, 2H), 1.55 (pent, J = 7.0 Hz, 2H), 2.13 (t, J = 7.5 Hz,
2H), 4.08 (t, J = 7.0 Hz, 2H), 4.46 (m, J = 4.0 Hz, 4H), 7.23 (t, J = 7.0 Hz, 3H), 7.28 (t, J = 7.0 Hz,
6H), 7.40 (d, J = 8.0 Hz, 6H), 7.74 (m, J = 4.0 Hz, 2H), 7.83 (m, J = 3.0 Hz, 2H); Figure 27. 13C NMR
(400 MHz, CDCl3): δ 25.4, 28.6, 32.0, 65.2, 66.6, 68.4, 75.7, 123.8, 126.7, 128.0, 129.0, 129.8,
134.8, 145.2, 155.1, 163.5.
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O-(6-(Tritylthio)hexyl)hydroxylamine (5). Hydrazine monohydrate (2.16 g, 43.11 mmol) was
added to a solution of 4 (5.25 g, 8.62 mmol) in dichloromethane (100 mL) and stirred at 0 ⁰C for
2 hours. The reaction was filtered and concentrated by rotary evaporation to give a colorless oil
-1

(4.06 g, 98% yield) which was used without further purification. Figure 18. IR ν (cm ) 3322,
1740, 1487, 1436, 1258, 1028; Figure 23. 1H NMR (500 MHz, CDCl3): δ 1.25 (m, J = 3.5 Hz, 4H),
1.38 (pent, J = 7 Hz, 2H), 1.58 (pent, J = 7 Hz, 2H), 2.14 (t, J = 7 Hz, 2H), 3.86 (t, J = 4 Hz, 2H), 4.07
(t, J = 6.5 Hz, 2H), 4.33 (t, J = 4.5 Hz, 2H), 5.52 (s, 1H), 7.20 (t, J = 7 Hz, 3H), 7.27 (t, J = 7 Hz, 6H),
7.40 (d, J = 7.5 Hz, 6H); Figure 28. 13C NMR (400 MHz, CDCl3): δ 25.4, 28.5, 28.6, 28.7, 31.9, 65.4,
66.6, 68.2, 73.4, 126.7, 127.9, 129.8, 145.2, 155.6; HRMS m/z cald [C28H34NO4S]+ 480.2203,
observed 480.2206.
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(E)-2-(((2-(anthracen-9-yl)ethylidene)amino)oxy)ethyl (6-(tritylthio)hexyl) carbonate (6).
Anthracene aldehyde (0.494 g, 2.25 mmol) was added to 5 (1.08 g, 2.25 mmol) in
dichloromethane (10 mL) and stirred overnight. The solution was concentrated by rotary
evaporation to give an orange oil and was used without further purification. Figure 19. IR ν (cm
1

-

) 3290, 1743, 1664, 1443, 1488, 1257; Figure 24. 1H NMR (500 MHz, CDCl3): δ 1.24 (d, J = 24.3

Hz, 4H), 1.34 (t, J = 5.5 Hz, 2H), 1.52 (t, J = 6.5 Hz, 2H), 2.11 (t, J = 7.5 Hz, 2H), 4.03 (t, J = 6 Hz,
1H), 4.22 (s, 1H), 4.50 (t, J = 7.5 Hz, 2H), 6.73 (s, 1H), 7.19 (d, J = 6Hz, 3H), 7.25 (t, J = 6.5 Hz, 7H),
7.40 (d, J = 6 Hz, 6H), 7.46 (t, J = 7 Hz, 2H), 7.99 (d, J = 8.5 Hz, 2H), 8.26 (d, J = 9.5 Hz, 1H), 8.38
(s, 1H); Figure 29. 13C NMR (400 MHz, CDCl3): δ 25.2, 28.5, 31.8, 66.0, 66.5, 68.0, 71.2, 123.9,
125.1, 126.6, 127.2, 127.9, 129.7, 130.2, 131.5, 149.4, 150.5, 155.2.
II.

Loading the Linker System onto the Nanoparticles
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Trifluoroacetic acid (1.1 mmol, 11 mL) was added to 6 in an ice bath. Triethylsilane (3.3 mmol,
0.53 mL) was added dropwise, and the solution was stirred for 30 minutes. The solution was
concentrated via rotary evaporation and used without further purification or characterization.
The resulting reaction mixture was added to the gold-coated iron oxide nanoparticles at a ratio
of 0.01 mmol: 1.0 mg, linker: nanoparticles, in chloroform as solvent and stirred overnight. The
linker system was then precipitated with ethanol. The resulting solution was placed in a
centrifuge at 10,000 rpm for 15 minutes. The supernatant was discarded and the product was
dissolved in hexanes. Ethanol was added to, once again, precipitate the linker system before
being centrifuged. This process was repeated 5 times. 11 Both the synthesis of the gold-coated
Fe3O4 NPs and the loading process were developed by Sara Biladeau, a graduate student in the
Chemistry Department at the University of Louisville with whom I collaborated.

III.

Testing the Control Linker System Using an Alternating Magnetic Field

The control linker system was then subjected to an alternating magnetic field (AMF). The
machine used was an Ambrell system model EasyHeat-LI. The sample was loaded into a 3 mL
polystyrene cuvette and placed into the center of the coil (as shown in the picture below).

19

Figure 11. Setup of the AMF studies.
A narrow coil of tubing through which air flows was placed between the cuvette and the inner
portion of the magnetic coil so as to reduce undesired heating of the bulk solution from the
magnetic coil. The sample was then subjected to the AMF for a period of 15 minutes at 500 A
and 204 kHz. These conditions were chosen so as to be comparable to Sara Biladeau’s aminebased linker that also utilized anthracene as a payload. She noted that after 15 minutes under
these conditions, maximum anthracene release was reached. With those results in hand, I
decided to replicate the conditions used in her studies to compare results of both the aminebased and amine-deficient linker systems.
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IV.

Analytical Analysis Using Matrix-assisted Laser Desorption/Ionization Time of
Flight (MALDI-TOF)

Analysis of the supernatant was performed on a Voyager DE-Pro MALDI-TOF instrument (PE
Biosystems). A sample solution was prepared for the instrument, and 0.5 µL was used to spot
the wells of the MALDI plate and allowed to dry. Calibration was acquired by using known peaks
from the 2,5-dihydroxybenzoic acid matrix.11

21

Chapter 3
Part A: Results
The results from the MALDI-TOF analysis of the supernatant from the AMF exposed linker
system revealed that none of the payload had been released. The desired fragment, along with
its mass, is shown below in Figure 12.

Figure 12. The alcohol fragment which indicates release of payload.

Special attention was placed on the area of the spectrum around the mass at m/z = 279, the
mass of the payload, had it been released. As can be seen from the below spectrum, no signal
was detected near a mass at m/z = 279, suggesting that the payload was not cleaved under the
AMF exposure conditions studied.

22

In contrast, when MALDI-TOF analysis was performed upon the supernatant of the linker
system after it had been reduced by lithium aluminum hydride (LAH), the following spectrum
was obtained.

23

As can be seen in the figure, the signal at exactly m/z = 279 reveals that the reduction had
succeeded in cleaving the payload from the NP. However, some of the extra peaks in the
spectrum cannot be identified as representative of the matrix solution used for MALDI-TOF.
With a powerful reducing agent such as LAH, it is possible that the extreme conditions could be
the explanation for the extra peaks, as undesired by-products may have been formed in the
process. One such product, the amine shown below, was observed in higher concentration than
the expected oxime ether.

Figure 13. Oxime ether reduction product.
This product, the result of the complete reduction of the oxime ether to an amine, reveals the
power of LAH as a reducing agent. Thus, while the desired peaks representing the payload
were observed, the presence of unidentifiable peaks brings about much speculation. Therefore,
a new approach implemented by Sara Biladeau on her amine-based system, was used to obtain
clearer results. This approach includes using dithiothreitol (DTT) to cleave the gold-thiol bond
thus removing the entire linker system from the gold-coated iron oxide NPs. Performing a DTT
reduction is a much milder approach than the LAH reduction. MALDI-TOF analysis of the
supernatant of this method is shown in the spectrum below.
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Analysis of this spectrum revealed the desired peak at m/z = 478, indicative of the potassiated
form of the entire linker system. All other signals can be attributed to the matrix used to run
the sample. This evidence reveals that the payload had been successfully loaded onto the NPs

25

Part B: Conclusion
The MALDI-TOF results suggest that the control non-nucleophilic linker system did not release
the fluorophore payload upon exposure to an AMF. This was evidenced by the lack of a mass
signal at m/z = 279 corresponding to the fragment expected on reaction of the carbonate
cleavage. While promising, this negative result is not sufficient by itself to confidently say that
the payload did not release. With that in mind, we set out to establish that the fluorophore was
still attached after AMF treatment. The linker system was subjected to the powerful reducing
agent LAH to reduce the carbonate group so as to release the fluorophore. Analysis of the
organic soluble fraction after reduction revealed two things: 1.) the anthracene payload was
now detected by MALDI-TOF at the expected mass m/z = 279 and as an amine at the mass m/z
= 244; and 2.) the linker system did indeed still contain the payload. However, as mentioned
earlier, this method may not have been an ideal one; therefore, further studies with DTT as a
milder reducing agent which facilitated the cleavage of the gold-thiol bond to release the entire
linker system were performed to provide more definitive evidence. Thus, without the presence
of the nucleophilic amine, intramolecular cyclization was prevented, resulting in retention of
the payload. When the linker system was treated with hydride to cleave the carbonate, the
payload was observed. As predicted in the hypothesis of this experiment, it can be confidently
stated that the non-nucleophilic linker system does not significantly release the payload upon
exposure to the AMF due to its lack of a nucleophilic element.
The work performed so far by Sara Biladeau and her linker system with a nucleophilic
element (amine)11 has shown promising results. With a foresight of medical applications, she
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utilized a water soluble fluorophore, FITC, as a payload. This allows for testing to be performed
under conditions that can be extremely similar to the human body’s own internal chemical
environment.
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Figure 14. Graphical representation of the percent release of the amine-based linker system vs.
the amine-deficient linker system. LS1 = amine-based linker system; LS2 = amine-deficient
linker system.11

As can be observed from Figure 14, the amine-based linker system shows significant
release of its payload when subjected to an AMF while the amine-deficient linker system does
not show significant release of its payload.11
Proving the concept that the presence of an amine is responsible for payload release
from this linker system has an impact which reaches beyond the laboratory. If the payload were
to be a potent drug, such as the cancer drug Doxorubicin, this linker system would have the
potential to more precisely deliver this highly toxic chemotherapeutic agent. Loading the linker
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system with a “cocktail” of drugs also could pave the path for personalized treatment plans in
the medical community.
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Figure 15: IR spectrum of product 2.
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Figure 16: IR spectrum of product 3.
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Figure 17: IR Spectrum of product 4.
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Figure 18: IR spectrum of product 5.
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Figure 19: IR spectrum of product 6.
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Figure 20: 1H NMR spectrum of product 2.
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Figure 21: 1H NMR spectrum of product 3.
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Figure 22: 1H NMR spectrum of product 4.
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Figure 23: 1H NMR spectrum of product 5.
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Figure 24: 1H NMR spectrum of product 6.
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Figure 25: 13C NMR spectrum of product 2.
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Figure 26: 13C NMR spectrum of product 3.
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Figure 27: 13C NMR spectrum of product 4.
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Figure 28:

13C

NMR spectrum of product 5.
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Figure 29: 13C NMR spectrum of product 6.
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